Skip Navigation

Palliative photodynamic therapy for advanced oesophageal cancer

Guidance issued Guidance issued
 
IP Guidance Number: IPG206
 
Summary:
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on palliative photodynamic therapy for advanced oesophageal cancer.
Description:
PDT uses light to kill cancer cells. You have to take a drug that makes your body cells sensitive to light. Then the doctor shines a very bright light onto the cancer cells. This activates the drug and kills the cells.
Arrangements:

Other (see guidance)

Topic Area:

Cancer
Digestive system

Specialty:

Clinical oncology
Medical oncology
Palliative medicine

Specialist advice has
been sought from:

Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland

British Society of Gastroenterology

British Association of Surgical Oncology

 

Date notified to NICE: 08 April 2005
Provisional Consultation Date: Autumn 2006
Guidance Publication Date: 24 January 2007
Contact Details:
Project Manager
(for general enquiries or comments)
Ben Doak
ip@nice.org.uk
Technical Lead
(for procedure specific enquiries or comments)
Steven Barnes
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA


Links:

Search NICE guidance


Advanced guidance search

Related guidance

Click the links below to see guidance on similar topics